Teva rolls out QVAR RediHaler in U.S.
JERUSALEM, Israel — Teva Pharmaceutical Industries Ltd. has made its QVAR RediHaler Inhalation Aerosol (beclomethasone dipropionate HFA) commercially available in 40-mcg and 80-mcg strengths in the United States. The QVAR RediHaler is the first and only breath-actuated aerosol inhaled corticosteroid for the maintenance treatment of asthma as a prophylactic therapy in patients ages 4 years and older,
